Most cells in the body, in their resting state, are in which phase of cellular respiration?
In the TCA cycle, from which enzyme is CO2 released?
The citric acid cycle is the final pathway for oxidation of?
Complex I of the electron transport chain is inhibited by which of the following substances?
Which of the following molecules does not regulate the Citric Acid Cycle (TCA)?
Antimycin A inhibits which complex of the electron transport chain?
Which enzyme complex corresponds to Complex I in the electron transport chain?
Per turn of the TCA cycle, how many ATP are generated from 3 NADH and 1 FADH2?
Which one of the following tissues can metabolize glucose, fatty acids, and ketone bodies for ATP production?
Which is the only non-protein component of the Electron Transport Chain (ETC)?
Explanation: **Explanation:** The concept of "Phases of Cellular Respiration" refers to the metabolic state of the mitochondria based on the availability of ADP, substrates, and oxygen. This classification is known as the **Chance and Williams states of respiratory control.** **Why Phase 4 is Correct:** In a resting cell, the energy demand is low, meaning ATP levels are high and **ADP levels are low**. Since ADP is the primary rate-limiting factor for the Electron Transport Chain (ETC), its scarcity slows down respiration. **State 4 (Phase 4)** is defined as the "resting state" where all components (oxygen, fuel, and mitochondria) are present, but the **low concentration of ADP** limits the rate of oxygen consumption. Once the cell becomes active and uses ATP, ADP levels rise, shifting the cell into State 3 (active respiration). **Analysis of Incorrect Options:** * **Phase 1:** This is the state where only mitochondria are present, and they are waiting for endogenous substrates and ADP. * **Phase 2:** This state occurs when substrate (fuel) is added, but ADP is still lacking. Respiration is very slow. * **Phase 3:** This is the **active state**. It occurs when ADP is added to a system with substrate and oxygen. This is the state of maximal respiration found in exercising muscles or metabolically active tissues. **NEET-PG High-Yield Pearls:** * **Respiratory Control:** The regulation of the rate of oxidative phosphorylation by the level of ADP is called "Acceptor Control." * **State 3 vs. State 4:** The ratio of the rate of respiration in State 3 to State 4 is called the **Respiratory Control Index (RCI)**, which indicates the tightness of coupling in mitochondria. * **Uncouplers:** Substances like 2,4-DNP bypass respiratory control, causing the cell to act as if it is in a permanent State 3, leading to excessive heat production.
Explanation: **Explanation:** In the Tricarboxylic Acid (TCA) cycle, energy is harvested through a series of oxidative decarboxylation reactions. There are two specific steps where carbon is removed from the substrate and released as **CO₂**: 1. **Isocitrate → α-Ketoglutarate** (catalyzed by Isocitrate Dehydrogenase) 2. **α-Ketoglutarate → Succinyl-CoA** (catalyzed by **α-Ketoglutarate Dehydrogenase**) **Alpha-ketoglutarate dehydrogenase** is the correct answer as it catalyzes the second oxidative decarboxylation. This enzyme complex requires five cofactors (TPP, Lipoate, CoA, FAD, and NAD⁺) and is a key regulatory point of the cycle. **Analysis of Options:** * **A. Thioinase:** This is not an enzyme of the TCA cycle; it is generally associated with the degradation of thiamine (Vitamin B1). * **B. Isocitrate dehydrogenase:** While this enzyme *does* release CO₂, the question asks to identify the enzyme from the provided list. In many competitive exams, if both are present, the specific phrasing or context usually points to α-KGDH as the "rate-limiting" decarboxylation step, though technically both B and D are decarboxylases. (Note: In this specific MCQ set, D is marked as the intended answer). * **C. Citrate dehydrogenase:** This enzyme does not exist. The enzyme that acts on citrate is **Aconitase**, which isomerizes citrate to isocitrate. **High-Yield Clinical Pearls for NEET-PG:** * **Cofactor Requirement:** The α-KGDH complex requires the same five cofactors as the Pyruvate Dehydrogenase (PDH) complex. A deficiency in **Thiamine (B1)** inhibits these enzymes, leading to lactic acidosis and Wernicke-Korsakoff syndrome. * **Arsenite Poisoning:** Arsenite inhibits α-KGDH by binding to the -SH groups of **Lipoic acid**, leading to a clinical presentation similar to thiamine deficiency. * **Energy Yield:** Each turn of the TCA cycle produces **10 ATP** (3 NADH, 1 FADH₂, 1 GTP).
Explanation: The **Citric Acid Cycle (TCA cycle or Krebs cycle)** is the final common oxidative pathway for the major energy-yielding macromolecules. ### 1. Why "None of the above" is correct The TCA cycle is the final pathway for the oxidation of **Carbohydrates, Lipids (Fats), and Proteins**. These macronutrients are converted into **Acetyl-CoA** (or other cycle intermediates), which then enters the cycle to be oxidized into $CO_2$ and $H_2O$, while generating reduced coenzymes ($NADH$ and $FADH_2$) for the Electron Transport Chain. Since the options provided (Enzymes, Vitamins, Minerals) are not primary fuel sources for oxidation, "None of the above" is the correct choice. ### 2. Why other options are incorrect * **Enzymes (A):** These are biological catalysts (mostly proteins) that facilitate reactions but are not consumed as fuel for energy production. * **Vitamins (B):** These act as essential **coenzymes** or precursors (e.g., Thiamine as TPP, Riboflavin as FAD, Niacin as NAD) that help the cycle function, but they are not the substances being oxidized for energy. * **Minerals (C):** These act as inorganic **cofactors** (e.g., $Mg^{2+}$, $Fe^{2+}$) for various enzymes within the cycle but do not undergo oxidation to provide ATP. ### 3. High-Yield Clinical Pearls for NEET-PG * **Amphibolic Nature:** The TCA cycle is both catabolic (breaks down Acetyl-CoA) and anabolic (provides precursors for gluconeogenesis and amino acid synthesis). * **Location:** Occurs entirely in the **Mitochondrial Matrix**. * **Rate-limiting Enzyme:** Isocitrate Dehydrogenase. * **Key Coenzymes:** The conversion of Pyruvate to Acetyl-CoA (via PDH complex) and $\alpha$-ketoglutarate to Succinyl-CoA requires five cofactors: **T**hiamine (B1), **R**iboflavin (B2), **N**iacin (B3), **L**ipoic acid, and **C**oA (B5) — Mnemonic: **T**ender **R**oving **N**ights **L**ove **C**are.
Explanation: **Explanation:** The Electron Transport Chain (ETC) consists of five complexes located in the inner mitochondrial membrane. **Complex I (NADH-Q oxidoreductase)** is responsible for transferring electrons from NADH to Coenzyme Q. **Why Amobarbital is correct:** **Amobarbital** (a barbiturate) is a classic inhibitor of Complex I. It blocks the transfer of electrons from the Iron-Sulfur (Fe-S) centers of Complex I to Ubiquinone (CoQ). Other notable inhibitors of Complex I include **Rotenone** (a pesticide), **Piericidin A** (an antibiotic), and **MPTP** (associated with drug-induced Parkinsonism). **Why the other options are incorrect:** * **Cyanide (CN⁻), Carbon Monoxide (CO), and Hydrogen Sulfide (H₂S):** These are all potent inhibitors of **Complex IV (Cytochrome c oxidase)**. They bind to the heme iron (Fe³⁺ or Fe²⁺) within the complex, preventing the final transfer of electrons to oxygen, effectively halting aerobic respiration. **High-Yield Clinical Pearls for NEET-PG:** * **Complex II Inhibitors:** Carboxin and Malonate (a competitive inhibitor of Succinate Dehydrogenase). * **Complex III Inhibitors:** Antimycin A and British Anti-Lewisite (BAL). * **Complex V (ATP Synthase) Inhibitor:** Oligomycin (closes the H⁺ channel). * **Uncouplers:** 2,4-Dinitrophenol (DNP) and Thermogenin (brown fat). Unlike inhibitors, uncouplers increase oxygen consumption but decrease ATP synthesis by dissipating the proton gradient as heat.
Explanation: The Citric Acid Cycle (TCA cycle) is the central metabolic pathway for energy production, and its regulation is primarily governed by the **energy status of the cell**. ### Why NADPH is the Correct Answer **NADPH** is primarily involved in **reductive biosynthesis** (e.g., fatty acid synthesis, cholesterol synthesis) and the regeneration of reduced glutathione to combat oxidative stress. It is generated via the Pentose Phosphate Pathway (PPP) and Malic enzyme, but it does **not** act as a regulatory ligand for any of the rate-limiting enzymes of the TCA cycle (Citrate Synthase, Isocitrate Dehydrogenase, or α-Ketoglutarate Dehydrogenase). ### Why the Other Options are Incorrect The TCA cycle is regulated by the **ATP/ADP ratio** and the **NADH/NAD+ ratio**: * **ATP & NADH (Options A & B):** These are signals of high energy status. They act as **allosteric inhibitors** of key enzymes like Isocitrate Dehydrogenase. When energy levels are high, the cycle slows down. * **ADP (Option D):** This is a signal of low energy status. It acts as an **allosteric activator**, specifically increasing the affinity of Isocitrate Dehydrogenase for its substrate, thereby speeding up the cycle to produce more energy. ### High-Yield NEET-PG Pearls * **Rate-Limiting Enzyme:** Isocitrate Dehydrogenase is the primary rate-limiting step of the TCA cycle. * **Calcium (Ca²⁺):** In muscle tissue, Ca²⁺ acts as a potent activator of the TCA cycle (linking muscle contraction to energy production). * **Fluoroacetate:** A potent inhibitor of the TCA cycle that inhibits the enzyme **Aconitase** (suicide inhibition). * **Arsenite:** Inhibits the **α-Ketoglutarate Dehydrogenase** complex (similar to its action on Pyruvate Dehydrogenase).
Explanation: **Explanation:** The Electron Transport Chain (ETC) consists of a series of protein complexes located in the inner mitochondrial membrane that facilitate oxidative phosphorylation. **Antimycin A** is a potent inhibitor that specifically binds to the **Qi site of Complex III** (Cytochrome bc1 complex). By doing so, it blocks the transfer of electrons from Cytochrome b to Cytochrome c1, effectively halting the proton gradient formation and ATP synthesis. **Analysis of Options:** * **Complex I (NADH Dehydrogenase):** Inhibited by **Rotenone**, Piericidin A, and barbiturates like **Amobarbital**. It is not affected by Antimycin A. * **Complex II (Succinate Dehydrogenase):** Inhibited by **Malonate** (a competitive inhibitor) and Carboxin. This complex does not pump protons and is bypassed by electrons entering from NADH. * **Complex III (Cytochrome bc1 complex):** This is the **correct** target for Antimycin A. Inhibition here prevents the "Q-cycle" from completing. * **Complex IV (Cytochrome c Oxidase):** Inhibited by **Cyanide (CN⁻)**, **Carbon Monoxide (CO)**, Hydrogen Sulfide ($H_2S$), and Azides ($NaN_3$). These bind to the iron in heme $a_3$. **High-Yield Clinical Pearls for NEET-PG:** * **Oligomycin** is an inhibitor of **Complex V** (ATP Synthase), specifically the $F_o$ subunit. * **Uncouplers** (e.g., 2,4-Dinitrophenol, Thermogenin, high-dose Aspirin) dissipate the proton gradient as heat rather than inhibiting the complexes directly. * Inhibition of any complex (I-IV) leads to a decrease in oxygen consumption and ATP production, whereas uncouplers increase oxygen consumption while stopping ATP synthesis.
Explanation: **Explanation:** The Electron Transport Chain (ETC) consists of four multi-enzyme complexes located in the inner mitochondrial membrane. **Complex I**, also known as **NADH-Coenzyme Q reductase** (or NADH dehydrogenase), is the first entry point for electrons. It catalyzes the transfer of two electrons from NADH to Coenzyme Q (Ubiquinone) while simultaneously pumping four protons ($H^+$) into the intermembrane space, contributing to the proton gradient required for ATP synthesis. **Analysis of Options:** * **Option A (Correct):** NADH-Coenzyme Q reductase is the systematic name for Complex I, reflecting its role in oxidizing NADH and reducing Coenzyme Q. * **Option B (Incorrect):** Coenzyme Q-cytochrome c reductase refers to **Complex III**. It transfers electrons from reduced ubiquinone ($QH_2$) to Cytochrome c. * **Option C (Incorrect):** Cytochrome-c oxidase refers to **Complex IV**. It is the terminal oxidase that transfers electrons to molecular oxygen to form water. * **Complex II** (not listed) is Succinate-Coenzyme Q reductase (Succinate dehydrogenase). **High-Yield NEET-PG Pearls:** * **Prosthetic Groups:** Complex I contains **FMN** (Flavin Mononucleotide) and **Fe-S** (Iron-Sulfur) centers. * **Inhibitors:** Complex I is specifically inhibited by **Rotenone**, **Amobarbital** (Amytal), and **Piericidin A**. * **Clinical Correlation:** Mutations in Complex I subunits are the most common cause of **Leber’s Hereditary Optic Neuropathy (LHON)** and **Leigh Syndrome**. * **Proton Pumping:** Complexes I, III, and IV act as proton pumps; **Complex II does not pump protons**, which is why $FADH_2$ yields less ATP than NADH.
Explanation: ### Explanation **1. Why Option B (9) is Correct:** The yield of ATP from reduced coenzymes depends on the **Electron Transport Chain (ETC)** and the process of oxidative phosphorylation. According to current bioenergetic standards (P:O ratios): * **1 NADH** generates **2.5 ATP** when oxidized via the ETC. * **1 FADH₂** generates **1.5 ATP** because it enters the ETC at Complex II, bypassing the first proton-pumping site (Complex I). **Calculation per turn of the TCA cycle:** * 3 NADH × 2.5 = 7.5 ATP * 1 FADH₂ × 1.5 = 1.5 ATP * **Total = 9 ATP** *Note: While older textbooks used integers (3 for NADH, 2 for FADH₂), modern biochemistry (Harper’s, Lehninger) and current NEET-PG patterns follow the 2.5/1.5 ratio.* **2. Why Other Options are Incorrect:** * **Option A (6):** This value is too low and does not account for the full oxidative potential of the four coenzymes. * **Option C (12):** This represents the **total energy yield** per turn of the TCA cycle if you include the **1 GTP** (equivalent to 1 ATP) produced via substrate-level phosphorylation (3 NADH [7.5] + 1 FADH₂ [1.5] + 1 GTP [1] = 10 ATP). Using the older ratios (3+3+3+2+1), it would equal 12. However, the question specifically asks for ATP generated *from* the coenzymes only. * **Option D (15):** This value is incorrect for a single turn of the TCA cycle; it may be confused with the total ATP yield from one molecule of Pyruvate (which includes Pyruvate Dehydrogenase reaction). **3. High-Yield Facts for NEET-PG:** * **Substrate Level Phosphorylation (SLP):** In the TCA cycle, this occurs during the conversion of **Succinyl CoA to Succinate** (catalyzed by Succinate thiokinase). * **Only Membrane-Bound Enzyme:** **Succinate Dehydrogenase** is the only TCA enzyme located in the inner mitochondrial membrane (it is also Complex II of the ETC). * **Total ATP per Glucose:** Under aerobic conditions, one molecule of glucose yields **30 or 32 ATP**, depending on the shuttle used (Malate-Aspartate vs. Glycerol-3-Phosphate).
Explanation: **Explanation:** The correct answer is **Muscle**. Skeletal muscle is a metabolic powerhouse capable of utilizing all three major fuel sources—glucose, fatty acids, and ketone bodies—depending on the intensity of exercise and the body's nutritional state. 1. **Why Muscle is Correct:** * **Glucose:** Used via glycolysis and the TCA cycle (especially during high-intensity work). * **Fatty Acids:** The preferred fuel during rest and low-intensity aerobic exercise (via $\beta$-oxidation). * **Ketone Bodies:** During starvation or prolonged fasting, muscles utilize acetoacetate and $\beta$-hydroxybutyrate by converting them back into Acetyl-CoA for the TCA cycle. 2. **Why Other Options are Incorrect:** * **Liver:** While the liver *produces* ketone bodies (ketogenesis), it **cannot** utilize them for energy because it lacks the enzyme **thiophorase** (succinyl-CoA:3-ketoacid CoA-transferase). * **Brain:** The brain primarily uses glucose. It can adapt to use ketone bodies during prolonged starvation, but it **cannot** utilize fatty acids because they are bound to albumin and cannot cross the blood-brain barrier. * **Red Blood Cells (RBCs):** RBCs lack mitochondria. Therefore, they cannot perform $\beta$-oxidation or the TCA cycle; they rely exclusively on **anaerobic glycolysis** for ATP. **High-Yield Facts for NEET-PG:** * **Thiophorase Deficiency:** The liver is the "producer but not the consumer" of ketone bodies due to the absence of thiophorase. * **Heart Muscle:** Like skeletal muscle, the heart is a major consumer of ketone bodies and actually prefers fatty acids as its primary fuel source. * **RBC Fuel:** Always remember: No mitochondria = No aerobic metabolism (No TCA, No $\beta$-ox, No Ketolysis).
Explanation: **Explanation:** The Electron Transport Chain (ETC) consists of a series of protein complexes (I-IV) and mobile carriers located in the inner mitochondrial membrane. **Coenzyme Q (CoQ)**, also known as **Ubiquinone**, is the only **non-protein** component of the ETC. Chemically, it is a lipophilic benzoquinone derivative with a long isoprenoid tail, allowing it to diffuse freely within the lipid bilayer. It functions as a mobile electron carrier, transferring electrons from Complexes I and II to Complex III. **Analysis of Options:** * **Cytochrome c (Option A):** While it is also a mobile carrier, it is a **small peripheral membrane protein** containing a heme group. It transfers electrons from Complex III to Complex IV. * **Complex V (Option C):** Also known as **ATP Synthase**, this is a large, multi-subunit **protein complex** responsible for oxidative phosphorylation, not a non-protein component. * **Complex II (Option D):** Also known as **Succinate Dehydrogenase**, this is a membrane-bound **enzyme (protein)** that links the TCA cycle to the ETC. **High-Yield Clinical Pearls for NEET-PG:** * **Statins and CoQ10:** HMG-CoA reductase inhibitors (Statins) inhibit the synthesis of mevalonate, a precursor for both cholesterol and the isoprenoid side chain of CoQ10. This deficiency is a proposed mechanism for **statin-induced myopathy**. * **Solubility:** CoQ is the only lipid-soluble component, whereas Cytochrome c is water-soluble (located in the intermembrane space). * **Inhibitors:** Remember that **Rotenone** inhibits electron transfer from Complex I to CoQ.
Bioenergetics and Thermodynamics
Practice Questions
ATP as Energy Currency
Practice Questions
Tricarboxylic Acid Cycle
Practice Questions
Electron Transport Chain
Practice Questions
Oxidative Phosphorylation
Practice Questions
Mitochondrial Diseases
Practice Questions
Uncouplers and Inhibitors of Oxidative Phosphorylation
Practice Questions
Shuttle Systems: Malate-Aspartate and Glycerol-Phosphate
Practice Questions
Energy Yield from Nutrients
Practice Questions
Metabolic Rate and Basal Metabolism
Practice Questions
Brown Adipose Tissue and Thermogenesis
Practice Questions
Oxygen Toxicity and Free Radicals
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free